Keywords: Breast, Diffusion/other diffusion imaging techniques, gradient nonlinearity correction, breast cancer, ADC
Motivation: MRI scanner gradient non-linearity (GNL) is a known source of variability and spatially-dependent bias in quantitative ADC measurements derived from diffusion-weighted imaging (DWI).
Goal(s): Evaluate the effects of GNL correction on DWI from the ACRIN 6698 multi-center trial, which investigated ADC as a marker breast cancer response in patients receiving neoadjuvant therapy.
Approach: Retrospective GNL correction was performed on the ACRIN 6698 DWI data
Results: Percent decrease in mean tumor ADC post-GNC ranged from 0.5%-11% for different MRI gradient sets, illustrating that GNL can confer significant bias to ADC measurements and should be corrected in multi-center clinical DWI trials.
Impact: Implementation of gradient non-linearity correction to reduce bias and variability of tumor ADC measurements from DWI data acquired in multi-center, multi-platform oncology trials may improve the quantitative utility of ADC for characterizing response to treatment.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords